中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
EVALUATION AND ANAL YSIS OF DRUG-USE IN HOSPITALS OF CHINA
2014年
12期
1126-1128,1129
,共4页
宋锦飞%徐琳%孙光春
宋錦飛%徐琳%孫光春
송금비%서림%손광춘
药品不良反应%临床表现%抗感染药%分析
藥品不良反應%臨床錶現%抗感染藥%分析
약품불량반응%림상표현%항감염약%분석
Adverse drug reaction%Clinical manifestation%Anti-infective drug%Analysis
目的：了解复旦大学附属上海市第五人民医院（以下简称“我院”）药品不良反应（ ADR）的发生情况，以促进临床合理用药。方法：回顾性调查2013年我院收集的217例ADR报告，从患者的年龄、性别、药品种类、给药途径等方面进行统计、分析。结果：217例ADR中，男女患者比例为0?7∶1?0；≥60岁患者78例（占35?94％）；静脉给药147例（占67?74％），口服给药59例（占27?19％）；抗感染药致ADR 119例，居首位；ADR临床表现主要为皮肤及其附件损害（80例，占36?87％）。结论：应加强医院ADR监测工作，合理、规范使用抗感染药，避免或减少严重的ADR发生。
目的：瞭解複旦大學附屬上海市第五人民醫院（以下簡稱“我院”）藥品不良反應（ ADR）的髮生情況，以促進臨床閤理用藥。方法：迴顧性調查2013年我院收集的217例ADR報告，從患者的年齡、性彆、藥品種類、給藥途徑等方麵進行統計、分析。結果：217例ADR中，男女患者比例為0?7∶1?0；≥60歲患者78例（佔35?94％）；靜脈給藥147例（佔67?74％），口服給藥59例（佔27?19％）；抗感染藥緻ADR 119例，居首位；ADR臨床錶現主要為皮膚及其附件損害（80例，佔36?87％）。結論：應加彊醫院ADR鑑測工作，閤理、規範使用抗感染藥，避免或減少嚴重的ADR髮生。
목적：료해복단대학부속상해시제오인민의원（이하간칭“아원”）약품불량반응（ ADR）적발생정황，이촉진림상합리용약。방법：회고성조사2013년아원수집적217례ADR보고，종환자적년령、성별、약품충류、급약도경등방면진행통계、분석。결과：217례ADR중，남녀환자비례위0?7∶1?0；≥60세환자78례（점35?94％）；정맥급약147례（점67?74％），구복급약59례（점27?19％）；항감염약치ADR 119례，거수위；ADR림상표현주요위피부급기부건손해（80례，점36?87％）。결론：응가강의원ADR감측공작，합리、규범사용항감염약，피면혹감소엄중적ADR발생。
OBJECTIVE:To investigate the characteristics of adverse drug reaction ( ADR ) in Shanghai Fifth People?s Hospital Affiliated to Fudan University ( hereinafter referred to as “our hospital“) so as to promote clinical rational use of drug. METHODS:217 ADR cases collected in our hospital during 2013 were analyzed statistically in terms of patients?age and gender, drug types and route of administration etc. RESULTS:The 217 ADR cases occurred in male/female ratio of 0?7∶ 1; 78 cases ( 35?94%) aged ≥60 years; 147 cases ( 67?74%) were induced via intravenous injection;59 cases(27?19%) were induced by oral drugs;the anti?infective drugs ranked the first in terms of ADR incidence; 80 cases ( 36?87%) manifested as lesions of skin and its appendants. CONCLUSIONS: It is important to strengthen ADR monitoring in hospital and achieve rational and standard use of anti?infective drugs so as to avoid or reduce the occurrence of severe ADR.
